NEW YORK, April 4  -Two weeks after penning a SNP collaboration with AstraZeneca, Lynx Therapeutics has agreed to perform gene expression assays for the Anglo-Swedish pharmaceutical giant using its MegaSort gene expression detection technology, Lynx said Wednesday.

Under the agreement, AstraZeneca will provide Lynx with tissue samples to analyze for differential gene expression patterns, and will make undisclosed milestone payments to Lynx. The parties did not disclose further terms of the agreement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.